Coskun U - Search Results

1

No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery.

Sancak B, Coskun U, Gunel N, Onuk E, Cihan A, Karamercan A, Yildirim Y, Ozkan S. Sancak B, et al. Among authors: coskun u. Intern Med J. 2004 Jun;34(6):310-5. doi: 10.1111/j.1444-0903.2004.00591.x. Intern Med J. 2004. PMID: 15228391

2

Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients.

Coşkun U, Günel N, Sancak B, Günel U, Onuk E, Bayram O, Yílmaz E, Candan S, Ozkan S. Coşkun U, et al. Breast. 2003 Apr;12(2):104-10. doi: 10.1016/s0960-9776(02)00214-x. Breast. 2003. PMID: 14659339

3

Serum big endothelin-1 levels in female patients with breast cancer.

Yildirim Y, Gunel N, Coskun U, Sancak B, Bukan N, Aslan S, Cetin A. Yildirim Y, et al. Among authors: coskun u. Int Immunopharmacol. 2008 Aug;8(8):1119-23. doi: 10.1016/j.intimp.2008.03.023. Epub 2008 Apr 28. Int Immunopharmacol. 2008. PMID: 18550016

4

Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer.

Coskun U, Günel N, Toruner FB, Sancak B, Onuk E, Bayram O, Cengiz O, Yilmaz E, Elbeg S, Ozkan S. Coskun U, et al. Neoplasma. 2003;50(1):41-6. Neoplasma. 2003. PMID: 12687277

5

Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer.

Coskun U, Gunel N, Onuk E, Yilmaz E, Bayram O, Yamac D, Cihan A, Ucan B, Yildirim Y, Celenkoglu G, Ozkan S. Coskun U, et al. Neoplasma. 2003;50(3):210-6. Neoplasma. 2003. PMID: 12937855

6

Serum levels of interleukin-18 and nitrite+nitrate in renal cell carcinoma patients with different tumor stage and grade.

Sözen S, Coskun U, Sancak B, Bukan N, Günel N, Tunc L, Bozkirli I. Sözen S, et al. Among authors: coskun u. Neoplasma. 2004;51(1):25-9. Neoplasma. 2004. PMID: 15004655

7

Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions.

Coskun U, Bukan N, Sancak B, Günel N, Ozenirler S, Unal A, Yucel A. Coskun U, et al. Neoplasma. 2004;51(3):209-13. Neoplasma. 2004. PMID: 15254675

8

Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients.

Coskun U, Gunel N, Sancak B, Onuk E, Bayram M, Cihan A. Coskun U, et al. Clin Exp Immunol. 2004 Sep;137(3):546-51. doi: 10.1111/j.1365-2249.2004.02579.x. Clin Exp Immunol. 2004. PMID: 15320904 Free PMC article.

9

Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy.

Gunel N, Akcali Z, Coskun U, Akyol G, Yamac D, Yenidünya S. Gunel N, et al. Among authors: coskun u. Pathol Res Pract. 2002;198(1):7-12. doi: 10.1078/0344-0338-00177. Pathol Res Pract. 2002. PMID: 11866215

10

Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients.

Günel N, Coşkun U, Sancak B, Günel U, Hasdemir O, Bozkurt S. Günel N, et al. Among authors: coskun u. Cancer. 2002 Aug 1;95(3):663-7. doi: 10.1002/cncr.10705. Cancer. 2002. PMID: 12209760 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters